APA (7th ed.) Citation

Chae, Y. K., Pan, A., Davis, A. A., Raparia, K., Mohindra, N. A., Matsangou, M., & Giles, F. J. (2016). Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection? Clinical lung cancer, 17(5), 350-361. https://doi.org/10.1016/j.cllc.2016.03.011

Chicago Style (17th ed.) Citation

Chae, Young Kwang, Alan Pan, Andrew A. Davis, Kirtee Raparia, Nisha A. Mohindra, Maria Matsangou, and Francis J. Giles. "Biomarkers for PD-1/PD-L1 Blockade Therapy In Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?" Clinical Lung Cancer 17, no. 5 (2016): 350-361. https://doi.org/10.1016/j.cllc.2016.03.011.

MLA (9th ed.) Citation

Chae, Young Kwang, et al. "Biomarkers for PD-1/PD-L1 Blockade Therapy In Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?" Clinical Lung Cancer, vol. 17, no. 5, 2016, pp. 350-361, https://doi.org/10.1016/j.cllc.2016.03.011.